Safinaz E. Abbas

721 total citations
19 papers, 619 citations indexed

About

Safinaz E. Abbas is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Safinaz E. Abbas has authored 19 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Safinaz E. Abbas's work include Synthesis and biological activity (9 papers), Quinazolinone synthesis and applications (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Safinaz E. Abbas is often cited by papers focused on Synthesis and biological activity (9 papers), Quinazolinone synthesis and applications (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Safinaz E. Abbas collaborates with scholars based in Egypt, Saudi Arabia and Italy. Safinaz E. Abbas's co-authors include Fadi M. Awadallah, Hanan H. Georgey, Riham F. George, Mohamed Farès, Hatem A. Abdel‐Aziz, Sahar M. Abou‐Seri, Gehan M. Kamel, Nagwa M. Abdel Gawad, Ahmed M. Gouda and Claudiu T. Supuran and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Safinaz E. Abbas

19 papers receiving 603 citations

Peers

Countries citing papers authored by Safinaz E. Abbas

Since Specialization

Citations

This map shows the geographic impact of Safinaz E. Abbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Safinaz E. Abbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Safinaz E. Abbas more than expected).

Fields of papers citing papers by Safinaz E. Abbas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Safinaz E. Abbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Safinaz E. Abbas. The network helps show where Safinaz E. Abbas may publish in the future.

Co-authorship network of co-authors of Safinaz E. Abbas

This figure shows the co-authorship network connecting the top 25 collaborators of Safinaz E. Abbas. A scholar is included among the top collaborators of Safinaz E. Abbas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Safinaz E. Abbas. Safinaz E. Abbas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Occupant’s Thermal Perception in Mixed-mode Office Buildings of the Tropical Climate 2024 ·(unknown), (unknown), (unknown), Safinaz E. Abbas	2
2	Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), Walaa R. Mahmoud, Fadi M. Awadallah, Azza T. Taher, Safinaz E. Abbas, Heba Abdelrasheed Allam, Daniela Vullo, Claudiu T. Supuran	8
3	Design and synthesis of new thienopyrimidine derivatives along with their antioxidant activity. 2021 ·Egyptian Journal of Chemistry ·Elshaymaa I. Elmongy, (unknown), (unknown), Safinaz E. Abbas	9
4	HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability 2020 ·Journal of Medicinal Chemistry ·(unknown), Safinaz E. Abbas, (unknown), Riham F. George, Hamdy Ali, (unknown), (unknown), Tamer E. Fandy, Khalid A. El Sayed, Zakaria Y. Abd Elmageed, (unknown), (unknown)	32
5	Design and synthesis of novel imidazo[4,5-b]pyridine based compounds as potent anticancer agents with CDK9 inhibitory activity 2018 ·Bioorganic Chemistry ·(unknown), Faten Farouk, Riham F. George, Safinaz E. Abbas, (unknown)	28
6	Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity 2017 ·Bioorganic Chemistry ·(unknown), Rabah A.T. Serya, (unknown), Ahmed Esmat, Safinaz E. Abbas, Dalal A. Abou El Ella	43
7	Design, Synthesis, and Biological Evaluation of Some Cyclohepta[b]Thiophene and Substituted Pentahydrocycloheptathieno[2,3‐d]Pyrimidine Derivatives 2016 ·Journal of Heterocyclic Chemistry ·Elshaymaa I. Elmongy, Mohammed A. Khedr, (unknown), Hanem M. Awad, Safinaz E. Abbas	9
8	Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives 2015 ·European Journal of Medicinal Chemistry ·Fadi M. Awadallah, (unknown), (unknown), Safinaz E. Abbas, Mariangela Ceruso, (unknown), Özen Özensoy Güler, Claudiu T. Supuran	53
9	Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest 2014 ·European Journal of Medicinal Chemistry ·Mohamed Farès, Sahar M. Abou‐Seri, Hatem A. Abdel‐Aziz, Safinaz E. Abbas, (unknown), (unknown)	106
10	4‐Substituted‐1‐phenyl‐1H‐pyrazolo[3,4‐d]pyrimidine Derivatives: Design, Synthesis, Antitumor and EGFR Tyrosine Kinase Inhibitory Activity 2014 ·Chemical Biology & Drug Design ·Safinaz E. Abbas, (unknown), Fadi M. Awadallah, Walaa R. Mahmoud	18
11	Synthesis, antitumor and antibacterial activities of some novel tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives 2013 ·European Journal of Medicinal Chemistry ·Safinaz E. Abbas, Nagwa M. Abdel Gawad, Riham F. George, (unknown)	59
12	Design and Synthesis of Some 3-Substituted-2-[(2,4-dichlorophenoxy)-methyl]quinazolin-4(3<i>H</i>)-one Derivatives as Potential Anticonvulsant Agents 2013 ·Chemical and Pharmaceutical Bulletin ·Safinaz E. Abbas, Fadi M. Awadallah, (unknown), (unknown), Gehan M. Kamel	9
13	Synthesis and antitumor activity of certain 2,3,6-trisubstituted quinazolin-4(3H)-one derivatives 2013 ·Bulletin of Faculty of Pharmacy Cairo University ·Safinaz E. Abbas, Flora F. Barsoum, Hanan H. Georgey, (unknown)	19
14	New quinazolinone–pyrimidine hybrids: Synthesis, anti-inflammatory, and ulcerogenicity studies 2012 ·European Journal of Medicinal Chemistry ·Safinaz E. Abbas, Fadi M. Awadallah, (unknown), (unknown), Gehan M. Kamel	76
15	Design, synthesis and preliminary evaluation of some novel [1,4]diazepino [5,6-b]pyrrolizine and 6-(2-oxopyrrolidino)-1H-pyrrolizine derivatives as anticonvulsant agents 2010 ·Medicinal Chemistry Research ·Safinaz E. Abbas, Fadi M. Awadallah, (unknown), Ahmed M. Gouda, (unknown)	12
16	Novel substituted and fused pyrrolizine derivatives: Synthesis, anti-inflammatory and ulcerogenecity studies 2009 ·European Journal of Medicinal Chemistry ·Safinaz E. Abbas, Fadi M. Awadallah, (unknown), Ahmed M. Gouda	37
17	SYNTHESIS OF CERTAIN PYRAZOLO[3,4-d] PYRIMIDINE DERIVATIVES OF POTENTIAL ANTI-INFLAMMATORY ACTIVITY 2008 ·Bulletin of Pharmaceutical Sciences Assiut ·Safinaz E. Abbas, Hanan H. Georgey, (unknown), (unknown)	1
18	Synthesis and Anticonvulsant Activity of Some Quinazolin-4-(3H)-one Derivatives 2008 ·Molecules ·Hanan H. Georgey, (unknown), Safinaz E. Abbas	95
19	SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SOME NOVEL 2,3-DISUBSTITUTED QUINAZOLIN4(3H)ONES 2007 ·Bulletin of Pharmaceutical Sciences Assiut ·Safinaz E. Abbas, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact